Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7314 p280
28 August 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


PSNC pharmacy development awards announced

The winners of the 2004 Pharmaceutical Services Negotiating Committee pharmacy development awards were announced this week.

The awards are made to local pharmaceutical committees to promote community pharmacy development. This year, two awards were made to East Riding and Hull LPC, one to South and West Devon LPC, and one to North and East Devon LPC. The PSNC said that the 2004 awards focus on innovative services or developments of existing services that promote the role of the community pharmacist and could be commissioned by primary care trusts.

In East Riding and Hull, one award was made for a weight management programme. Patients will be referred by their GP to a weight management support service provided by community pharmacists. Patients will visit the pharmacy every fortnight for lifestyle advice and measurement of body mass index, blood pressure, cholesterol level and waist circumference. The possibility of introducing a patient group direction for orlistat (Xenical) is being explored.

The second award in East Riding and Hull is for a project that will test the feasibility of involving community pharmacists in an existing national chlamydia awareness screening programme (CASPHER). Pharmacists will supply chlamydia testing kits and provide advice about how to use them.

The South and West Devon award will allow the evaluation of two community pharmacy-led medication review services for patients aged over 65 years. In one, patients were referred to pharmacists by a falls clinic and in the other by GPs. Structured reviews took place in the community pharmacy, at the patient’s home or at the falls clinic. The evaluation will compare the benefits of the locations in which the reviews took place. The evaluation will start next month and results are expected in early 2005.

North and East Devon LPC’s project will use community pharmacists to improve concordance among obese men taking statins. Patients who have been newly prescribed a statin will be either identified by pharmacists or referred by their GP. The pharmacist will then review the patient after one, four and 12 months. Patients will be given lifestyle information and compliance will be checked.

“The awards are allowing these projects to get off the ground,” commented Sue Taylor, chief officer of Devon LPCs. “They help to trigger communication between the LPC and PCT. We selected the areas for our bids for the awards by contacting the PCT and asking what areas we should make a bid in.”

Each project will receive up to £2,500. Details of the projects will be available shortly on the PSNC’s community pharmacy services database, which can be accessed here

Back to Top


©The Pharmaceutical Journal